SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-17-019907
Filing Date
2017-04-11
Accepted
2017-04-10 17:46:49
Documents
4
Period of Report
2017-05-15
Effectiveness Date
2017-04-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A v463929_def14a.htm DEF 14A 391501
2 GRAPHIC line.gif GRAPHIC 43
3 GRAPHIC sig_stevenh-rouhandeh.jpg GRAPHIC 17436
4 GRAPHIC spacer.gif GRAPHIC 43
  Complete submission text file 0001144204-17-019907.txt   417309
Mailing Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219
Business Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219 2149055100
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-15771 | Film No.: 17754557
SIC: 2834 Pharmaceutical Preparations